(6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane

C16H20BrN5O2S — CID 59020440

IUPAC(6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane
SMILES[H]N=S(C)(=O)c1ccc2cc1OCCCCCNc1nc(ncc1Br)N2
InChIInChI=1S/C16H20BrN5O2S/c1-25(18,23)14-6-5-11-9-13(14)24-8-4-2-3-7-19-15-12(17)10-20-16(21-11)22-15/h5-6,9-10,18H,2-4,7-8H2,1H3,(H2,19,20,21,22)
InChIKeySYEPFFZLELZIBK-UHFFFAOYSA-N
MW426.34 g/mol
LogP3.99
Rot. Bonds1

About (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane

(6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane (PubChem CID 59020440) has the molecular formula C16H20BrN5O2S and a molecular weight of 426.34 g/mol. Its IUPAC name is (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane.

Molecular Properties

Compound Name(6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane
PubChem CID59020440
Molecular FormulaC16H20BrN5O2S
Molecular Weight426.34 g/mol
Exact Mass425.05
IUPAC Name(6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane
SMILES[H]N=S(C)(=O)c1ccc2cc1OCCCCCNc1nc(ncc1Br)N2
InChIInChI=1S/C16H20BrN5O2S/c1-25(18,23)14-6-5-11-9-13(14)24-8-4-2-3-7-19-15-12(17)10-20-16(21-11)22-15/h5-6,9-10,18H,2-4,7-8H2,1H3,(H2,19,20,21,22)
InChIKeySYEPFFZLELZIBK-UHFFFAOYSA-N
XLogP3.99
TPSA99.99 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds1
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500426.34
LogP ≤ 53.99
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane?
The IUPAC name of (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane (CID 59020440) is (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane.
What is the SMILES notation for (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane?
The canonical SMILES for (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane is [H]N=S(C)(=O)c1ccc2cc1OCCCCCNc1nc(ncc1Br)N2.
What is the InChIKey of (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane?
The InChIKey is SYEPFFZLELZIBK-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H20BrN5O2S/c1-25(18,23)14-6-5-11-9-13(14)24-8-4-2-3-7-19-15-12(17)10-20-16(21-11)22-15/h5-6,9-10,18H,2-4,7-8H2,1H3,(H2,19,20,21,22).
What are the key properties of (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane?
(6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane has a molecular weight of 426.34 g/mol, XLogP of 3.99, 1 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (6-bromo-14-oxa-2,4,8,20-tetrazatricyclo[13.3.1.13,7]icosa-1(19),3,5,7(20),15,17-hexaen-16-yl)-imino-methyl-oxo-λ6-sulfane is sourced from PubChem (CID 59020440), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).